Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
IT | 965 kB | 921 |
This database contains classification and labelling information on notified and registered substances received from manufacturers and importers. It also includes the list of harmonised cl...
Regolamento delegato (UE) 2017/2100 della Commissione del 4 settembre 2017 che stabilisce criteri scientifici per la d...
Raccomandazione (UE) 2017/1936 della Commissione del 18 ottobre 2017 relativa a misure immediate volte a prevenire l'uso improprio dei precursori di esplosivi
Limitare la ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024